---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-106574"
form_type: "8-K/A"
ticker: "JSPR"
cik: "0001788028"
company_name: "Jasper Therapeutics, Inc."
filed_at: "2026-10-02T22:54:35+00:00"
generated_at: "2026-10-12T14:42:23.757777+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Jasper refiles Kira pro formas: $149M asset deal, $125M IPR&D charge, $132M PIPE nets $125M

## Summary
- Merger closed July 16, 2026: Jasper issued 5,195,009 Kira common shares at $0.774 and 4,644,977 preferred shares, total consideration ~$149.0M including $1.34M deal costs.
- Deal treated as an asset acquisition under ASC 805-50 with no goodwill; $125.2M of acquired IPR&D (KP-104 anti-C5 x Factor H and KP-701 anti-CD79B x CD32B) expensed at closing.
- PIPE financing: 4,655,951 preferred shares sold for ~$132.0M, closed July 20, 2026; net proceeds $124.8M after $6.98M placement agent fees; pro forma cash $142.8M at June 30, 2026.
- Mirador license (July 13, 2026) grants exclusive worldwide rights to KP-301 and KP-402: $12.0M upfront, $8.0M on delivery, up to $108.5M development and $350.0M commercial milestones.
- Pro forma FY2025 net loss $206.8M vs Jasper's stand-alone $75.8M; each pre-close common share gets one CVR paying pro-rata $30.0M if FDA grants a briquilimab Priority Review Voucher by Dec 31, 2028.

## SEC filing metadata
- accession: 0001213900-26-106574
- form_type: 8-K/A
- ticker: JSPR
- cik: 0001788028
- company_name: Jasper Therapeutics, Inc.
- filed_at: 2026-10-02T22:54:35+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1788028/000121390026106574/0001213900-26-106574-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1788028/000121390026106574/ea0307602-8ka2_jasper.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-106574
- JSON: https://secwatch.observer/filing/0001213900-26-106574.json
- Plain text: https://secwatch.observer/filing/0001213900-26-106574.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.